FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / disclosure-schedules.docx
disclosure-schedules.docx · 1013-00006

Parties

Genome Dx Therapeutics Inc
Harkness LLP
Towne Centre Properties LLC
Seller's Corp
Delaware General Corp
Lane LLP
California Source Inc

Dates

May 11, 2023
March 6, 2023
April 30, 2023
July 28, 2023
December 31, 2025
May 8, 2023
December 31, 2022
November 3, 2020
December 31, 2021
December 31, 2020

Amounts

$75,000
$47,600,000
$312,000,000
$6,800,000
$350,000
$6,450,000
$7,150,000
$250,000
$500,000
$140,000,000

Obligations

All capitalized terms used but not otherwise defined in these Disclosure Schedules shall have the respective meanings ascribed to such terms in the Agreement
All headings and section references contained in these Disclosure Schedules are for convenience of reference only, do not form a part of these Disclosure Schedules, and shall not affect in any way the meaning, construction, or interpretation of any provision of these Disclosure Schedules
1 of the Agreement, the following is a description of all assets owned or held by Seller that are exclusively related to, or exclusively used or held for use in connection with, the OncuPath Business (collectively, the "Purchased Assets"), which shall be transferred, conveyed, assigned, and delivered by Seller to Buyer at the Closing: I
The final inventory count shall be taken in accordance with the procedures set forth in Section 2
Seller shall retain copies of such books and records as may be necessary for Seller's tax, legal, or regulatory compliance obligations
2 of the Agreement, the following assets are excluded from the Purchased Assets and shall be retained by Seller (collectively, the "Excluded Assets"): 1